Michael S. Weiss
2020 - TG Therapeutics
In 2020, Michael S. Weiss earned a total compensation of $32.5M as Chief Executive Officer and President at TG Therapeutics, a 156% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $233,153 |
|---|---|
| Salary | $1,392,470 |
| Stock Awards | $30,871,615 |
| Total | $32,497,238 |
Weiss received $30.9M in stock awards, accounting for 95% of the total pay in 2020.
Weiss also received $233.2K in non-equity incentive plan and $1.4M in salary.
Rankings
In 2020, Michael S. Weiss' compensation ranked 93rd out of 13,090 executives tracked by ExecPay. In other words, Weiss earned more than 99.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 93 out of 13,090 | 99th |
Division Manufacturing | 21 out of 5,617 | 100th |
Major group Chemicals And Allied Products | 5 out of 2,248 | 100th |
Industry group Drugs | 5 out of 1,948 | 100th |
Industry Pharmaceutical Preparations | 3 out of 1,453 | 100th |
Source: SEC filing on April 29, 2022.
Weiss' colleagues
We found one more compensation record of an executive who worked with Michael S. Weiss at TG Therapeutics in 2020.
2020
Sean Power
TG Therapeutics